Cost-effectiveness of adding vaccination with the AS04-adjuvanted human papillomavirus 16/18 vaccine to cervical cancer screening in Hungary

BACKGROUND: The cervical cancer screening program implemented in Hungary to date has not been successful. Along with screening, vaccination is an effective intervention to prevent cervical cancer. The aim of this study was to assess the cost-effectiveness of adding vaccination with the human papillo...

Descripción completa

Detalles Bibliográficos
Autores principales: Vokó, Zoltán, Nagyjánosi, László, Kaló, Zoltán
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3528422/
https://www.ncbi.nlm.nih.gov/pubmed/23110361
http://dx.doi.org/10.1186/1471-2458-12-924

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3528422/
https://www.ncbi.nlm.nih.gov/pubmed/23110361
http://dx.doi.org/10.1186/1471-2458-12-924

Ejemplares similares